# Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients

> **NCT07432932** · — · RECRUITING · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 800 (estimated)

## Conditions studied

- Sarcoma
- Sarcoma, Leiomyo-, Adult
- Sarcoma, Synovial, Adult
- Soft Tissue Sarcoma (STS)
- Soft Tissue Sarcoma Adult
- Soft Tissue Sarcoma of the Trunk and Extremities
- Soft Tissue Sarcoma of the Limb
- Retroperitoneal Sarcoma
- Liposarcoma, Dedifferentiated
- Liposarcoma
- Leiomyosarcoma (LMS)
- Angiosarcoma

## Interventions

- **OTHER:** Observational Translational Study

## Key facts

- **NCT ID:** NCT07432932
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-19
- **Primary completion:** 2026-03-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2026-02-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07432932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07432932, "Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07432932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*